Peru

There is a critical need to tackle some of the more complicated and less understood causes of eye disease in the region such as retinopathy of prematurity (ROP) in premature babies and diabetic retinopathy (DR).

It is estimated that 7.3% of babies are born prematurely in Peru, which means ROP has become the leading cause of childhood blindness in the country. ROP leads to abnormal blood vessels growing in the retina causing it to detach from the back of the eye, leading to blindness.

From 2007 to 2016 we spearheaded two projects in 36 hospitals across Peru that focused on the urgent situation surrounding ROP. At the outset of the program, most hospitals had close to zero resources to address ROP, and local staff had very little understanding of the issue.

We worked alongside our partner, Instituto Damos Visión, to create an ROP referral network across Peru and a digital database to collect data on the prevalence and treatment of ROP in the northern and central regions. This evidence is used to advocate for change and suggest improvements to ROP protocols.

From 2014 to 2017, we worked with the Regional Institute of Ophthalmology (IRO) to improve screening, referrals, and treatment for diabetic retinopathy for people with diabetes–specifically lower-income patients enrolled in the public health insurance program. We trained professionals across the health system to ensure patients received the care they needed early enough for treatment to be successful.

In this time, we helped screen nearly 12,000 diabetic patients, a 78% increase from the previous years. From these, nearly 3,000 patients were found to have some form of diabetic retinopathy. In total, 923 patients were saved from a lifetime of blindness thanks to this partnership.

With approximately 4.5% of adults suffering from diabetes and diagnosis rates as low as 50% in some regions, diabetic retinopathy poses a huge risk. Everyone with diabetes is at risk of developing the condition as excessive blood sugar levels can cause irreversible damage to the vessels in the retina, which is why early detection and intervention is crucial in preventing blindness.

Since 2016, our efforts to improve access to eye care for infants and children have led to huge improvements in the quality of care available. We work directly with local partners to strengthen professional training, allowing residents to learn hands-on techniques to improve patient outcomes. We are also actively participating at a national level, working with the Ministry of Health (MINSA) to improve access to services and quality of care across the country.

Thanks to our supporters and partners, we've had a number of key successes in Peru:

Tripled the number of babies screened for ROP, and provided subsequent monitoring and oxygen therapy to those affected, leading to a significant reduction in the number of newborn babies requiring treatment
Implemented international best practices at partner hospitals that led to a decrease in the number of babies developing ROP
Established the first-ever Orbis Vision Center in Latin America
The Orbis Vision Center – part of the Hospital de Apoyo Leoncio Pradode Huamachuco - will give access to 80% of the population living in the Sanchez Carrion Province free access to comprehensive eye care
Successfully rolled out the mobile phone application "TeVeoBien" to conduct screening and follow-up for children in vulnerable communities.
Established DR services in three hospitals in Northern Peru.
Introduced ophthalmic services to Julcan, a remote rural town that previously had no access to eye care. Patient outreach in Julcan grew from 35 to 234 per month, demonstrating the transformative power of integrating vision centers into rural health systems.

We worked alongside our partner, Instituto Damos Visión, to create an ROP referral network across Peru and a digital database to collect data on the prevalence and treatment of ROP in the northern and central regions. This evidence is used to advocate for change and suggest improvements to ROP protocols.

From 2014 to 2017, we worked with the Regional Institute of Ophthalmology (IRO) to improve screening, referrals and treatment for diabetic retinopathy for people with diabetes - specifically lower income patients enrolled in the public health insurance. We trained professionals right cross the health system to ensure patients received the care they needed early enough for treatment to be successful.

Since 2015, we’ve been piloting a telemedicine program with the Regional Institute of Ophthalmology to train residents in cutting-edge techniques.

We are continuing our work with the Instituto Damos Visión to reduce blindness and visual impairment in premature babies in two regions of Peru – Lima and La Libertad. Together, we have worked tirelessly for a decade to make this disease a priority for health institutions, and more work is needed to ensure sustainability.

• Instituto Damos Visión
• Instituto Nacional De Oftalmologia (INO)
• Instituto Regional De Oftalmologia (IRO)